Project Co-financed by CDTI and ERDF funds
25/11/2021
![union europea](https://www.medichem.es/wp-content/uploads/2021/11/union-europea.jpg)
![cdti](https://www.medichem.es/wp-content/uploads/2021/11/cdti.png)
The project “Research and development of a drug for the treatment of acute lymphoblastic leukaemia and T-cell lymphoblastic lymphoma”, which aims to develop the active ingredient through the design of a synthesis methodology not developed so far, at Medichem’s Celrà facilities, has been co-financed by the Centre for the Development of Industrial Technology (CDTI) and the European Regional Development Fund (ERDF), A way for Europe, with an approved budget of 629,138€ for execution in 2020-2022.